Ismaiel A M, De Los Angeles J, Teitler M, Ingher S, Glennon R A
Department of Medicinal Chemistry, School of Pharmacy, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0540.
J Med Chem. 1993 Aug 20;36(17):2519-25. doi: 10.1021/jm00069a010.
DOM [i.e., 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane] is a 5-HT1C/2 serotonin agonist that exerts stimulus control of behavior in animals. In order to determine if the discriminative stimulus effect of DOM is 5-HT1C- or 5-HT2-mediated, it would be informative to conduct tests of stimulus antagonism with a 5-HT1C- or 5-HT2-selective antagonist. To date, no such agents exist. Although the neuroleptic agent spiperone binds at D2 dopamine receptors and 5-HT1A serotonin receptors, (a) it displays about a 1000-fold selectivity for 5-HT2 versus 5-HT1C sites and (b) it has been used as a "5-HT2-selective" antagonist. Because spiperone is a behaviorally disruptive agent, it is not suitable for use in drug-discrimination studies. Using the spiperone molecule as a starting point, a limited structure-affinity investigation was conducted in order to identify a suitable antagonist with high affinity and selectivity for 5-HT2 receptors, and yet an antagonist that might lack the disruptive actions of spiperone. Various modifications of the spiperone molecule were examined, but most resulted in decreased 5-HT2 affinity or in loss of selectivity. One compound, 8-[3-(4-fluorophenoxy)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]de can-4-on e (26), was shown to bind at 5-HT2 sites with high affinity (Ki = 2 nM) and > 2,000-fold selectivity versus 5-HT1C sites. In tests of stimulus antagonism using rats trained to discriminate 1 mg/kg of DOM from saline vehicle, 26 behaved as a potent antagonist (ED50 = 0.003 mg/kg) and lacked the disruptive effects associated with spiperone. As such, (a) it would appear that the DOM stimulus is primarily a 5-HT2-mediated, and not 5-HT1C-mediated, phenomenon, and (b) compound 26 may find application in other pharmacologic investigations where spiperone may not be a suitable antagonist.
DOM [即1-(2,5-二甲氧基-4-甲基苯基)-2-氨基丙烷] 是一种5-HT1C/2血清素激动剂,可对动物行为施加刺激控制。为了确定DOM的辨别性刺激效应是由5-HT1C还是5-HT2介导的,用5-HT1C或5-HT2选择性拮抗剂进行刺激拮抗试验将提供有用信息。迄今为止,尚无此类药物。尽管抗精神病药物螺哌隆可与D2多巴胺受体和5-HT1A血清素受体结合,(a) 它对5-HT2与5-HT1C位点的选择性约为1000倍,(b) 它已被用作 “5-HT2选择性” 拮抗剂。由于螺哌隆是一种会干扰行为的药物,因此不适合用于药物辨别研究。以螺哌隆分子为起点,进行了有限的结构-亲和力研究,以确定一种对5-HT2受体具有高亲和力和选择性的合适拮抗剂,同时也是一种可能缺乏螺哌隆干扰作用的拮抗剂。研究了螺哌隆分子的各种修饰,但大多数导致5-HT2亲和力降低或选择性丧失。一种化合物,8-[3-(4-氟苯氧基)丙基]-1-苯基-1,3,8-三氮杂螺[4.5]癸-4-酮 (26),显示出与5-HT2位点具有高亲和力结合 (Ki = 2 nM),对5-HT1C位点的选择性大于2000倍。在使用经训练以区分1 mg/kg DOM与生理盐水载体的大鼠进行的刺激拮抗试验中,26表现为强效拮抗剂 (ED50 = 0.003 mg/kg),且没有与螺哌隆相关的干扰作用。因此,(a) DOM刺激似乎主要是由5-HT2介导的现象,而非5-HT1C介导的现象,(b) 化合物26可能在其他药理研究中得到应用,而在这些研究中螺哌隆可能不是合适的拮抗剂。